Treatment typically begins with a low dose and is gradually increased at weekly or biweekly intervals
Moreover, UST elicited relatively inadequate responses in all three subtypes
As hormone levels change, so can body composition, fat distribution, and overall metabolic efficiency
Other key signaling pathways that are utilized are the mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) pathways, as well as SH2B1, a scaffold protein that interacts with JAK2 and mediates GH-induced changes in the cytoskeleton
Most bowel changes are most noticeable during initial treatment and often improve as your body adapts to the medication, typically within several weeks
To ensure optimal FcRn binding, cellular transport, and PK properties of albumin-based biologics, we attempted to substitute the C-terminal L585 of albumin with an amino acid residue that would not be recognized by CPA